Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jan 20;9(2):99.
doi: 10.3390/biomedicines9020099.

Flavonoids: Potential Candidates for the Treatment of Neurodegenerative Disorders

Affiliations
Review

Flavonoids: Potential Candidates for the Treatment of Neurodegenerative Disorders

Shweta Devi et al. Biomedicines. .

Abstract

Neurodegenerative disorders, such as Parkinson's disease (PD), Alzheimer's disease (AD), Amyotrophic lateral sclerosis (ALS), and Huntington's disease (HD), are the most concerning disorders due to the lack of effective therapy and dramatic rise in affected cases. Although these disorders have diverse clinical manifestations, they all share a common cellular stress response. These cellular stress responses including neuroinflammation, oxidative stress, proteotoxicity, and endoplasmic reticulum (ER)-stress, which combats with stress conditions. Environmental stress/toxicity weakened the cellular stress response which results in cell damage. Small molecules, such as flavonoids, could reduce cellular stress and have gained much attention in recent years. Evidence has shown the potential use of flavonoids in several ways, such as antioxidants, anti-inflammatory, and anti-apoptotic, yet their mechanism is still elusive. This review provides an insight into the potential role of flavonoids against cellular stress response that prevent the pathogenesis of neurodegenerative disorders.

Keywords: ER stress proteotoxicity; cellular stress response; flavonoids; neurodegenerative disorders; neuroinflammation; oxidative stress.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Role of flavonoids in prevention against cellular stress response. Exposure to stress conditions leads to the activation of cellular stress responses, such as UPR, ER stress, oxidative stress, proteotoxicity, and neuroinflammation. When cells are exposed to any stress condition, it affects the cellular proteome, thus inducing the UPR in the ER and further activation of ER stress. Stress conditions also initiate proteotoxicity by affecting the proteins’ structure, as well as proteasome subunits of the proteasomal degradation machinery, causing the release of misfolded/aggregated proteins in the cytosol, thus inducing proteotoxicity. The release of ROS from mitochondria leads to the generation of oxidative stress. All these cellular stress responses try to eliminate the stress-induced toxicity, but extreme cellular stress responses may lead to cell death. During stress exposure, microglia start to release neuroinflammatory mediators thus causing neuroinflammation. This inflammation creates a hostile environment within the cell and under harsh conditions, leads to cell death. Flavonoids have the potential to combat and prevent these exaggerated cellular stress responses in-turn preventing cell death. ER: Endoplasmic reticulum, ROS: Reactive oxygen species, UPR: Unfolded protein response.

Similar articles

Cited by

References

    1. Abeliovich A., Gitler A.D. Defects in trafficking bridge Parkinson’s disease pathology and genetics. Nature. 2016;539:207–216. doi: 10.1038/nature20414. - DOI - PubMed
    1. Canter R.G., Penney J., Tsai L.H. The road to restoring neural circuits for the treatment of Alzheimer’s disease. Nature. 2016;539:187–196. doi: 10.1038/nature20412. - DOI - PubMed
    1. Taylor J.P., Brown R.H., Jr., Cleveland D.W. Decoding ALS: From genes to mechanism. Nature. 2016;539:197–206. doi: 10.1038/nature20413. - DOI - PMC - PubMed
    1. Wyss-Coray T. Ageing, neurodegeneration and brain rejuvenation. Nature. 2016;539:180–186. doi: 10.1038/nature20411. - DOI - PMC - PubMed
    1. Focus on neurodegenerative disease. Nat. Neurosci. 2018;21:1293. doi: 10.1038/s41593-018-0250-x. - DOI - PubMed

LinkOut - more resources